On 6/11/24, Marker Therapeutics Inc (NASDAQ: MRKR) stock enjoyed a major increase of 11.2%, closing at $3.86. Moreover, this advance was accompanied by exceptionally high trading volume at 463% of normal. Relative to the market the stock has been strong over the last nine months but has declined -4.2% during the last week.
Current PriceTarget Research Rating
With future capital returns forecasted to fall short of the cost of capital, MRKR is expected to be a modest Value Eraser.
Marker Therapeutics has a current Value Trend Rating of F (Lowest Rating). The Value Trend Rating reflects inconsistent signals from PTR’s two proprietary measures of a stock’s attractiveness. Marker Therapeutics has a very low Appreciation Score of 8 but a neutral Power Rating of 54, resulting in the Lowest Value Trend Rating.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of F. This review will be completed in the next several days.
Be the first to comment